Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-27 4:05 pm Purchase | 2024-11-25 | 13D | Citius Pharmaceuticals, Inc. CTXR | Mazur Leonard L | 754,295 9.300% | 754,295 (New Position) | Filing History |
| 2024-08-16 4:34 pm Purchase | 2024-08-12 | 13D | Citius Oncology, Inc. CTOR | Citius Pharmaceuticals Inc. CTXR | 66,049,615 92.600% | 66,049,615 (New Position) | Filing History |
| 2024-05-08 2:22 pm Purchase | 2024-04-30 | 13G | Citius Pharmaceuticals, Inc. CTXR | BlackRock Inc. BLK | 345,034 4.800% | 6,721 (+1.99%) | Filing History |
| 2024-01-31 2:08 pm Purchase | 2023-12-31 | 13G | Citius Pharmaceuticals, Inc. CTXR | BlackRock Inc. BLK | 338,313 5.300% | 244,421 (+260.32%) | Filing History |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | Citius Pharmaceuticals, Inc. CTXR | BlackRock Inc. BLK | 93,892 1.600% | -231,239 (-71.12%) | Filing History |
| 2022-02-18 4:31 pm Purchase | 2019-04-03 | 13D | Citius Pharmaceuticals, Inc. CTXR | Mazur Leonard L | 723,685 11.760% | 280,719 (+63.37%) | Filing History |
| 2022-02-18 4:30 pm Purchase | 2019-04-03 | 13D | Citius Pharmaceuticals, Inc. CTXR | HOLUBIAK MYRON Z | 154,584 2.610% | 68,615 (+79.81%) | Filing History |
| 2022-02-14 6:44 pm Sale | 2021-12-31 | 13G | Citius Pharmaceuticals, Inc. CTXR | Armistice Capital, LLC | 97,000 1.600% | -149,734 (-60.69%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Citius Pharmaceuticals, Inc. CTXR | BlackRock Inc. BLK | 325,130 5.600% | 325,130 (New Position) | Filing History |
| 2021-02-16 3:00 pm Purchase | 2020-12-31 | 13G | Citius Pharmaceuticals, Inc. CTXR | Armistice Capital, LLC | 246,734 9.990% | 118,297 (+92.11%) | Filing History |